INVO Bioscience Inc (INVO)
0.88
-0.02
(-1.86%)
USD |
NASDAQ |
May 31, 16:00
0.866
-0.01
(-1.59%)
Pre-Market: 20:00
INVO Bioscience Cash from Financing (Quarterly): 0.5274M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.5274M |
| December 31, 2023 | -0.1415M |
| September 30, 2023 | 4.449M |
| June 30, 2023 | -0.1699M |
| March 31, 2023 | 3.255M |
| December 31, 2022 | 0.80M |
| September 30, 2022 | -0.0252M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.315M |
| December 31, 2021 | 3.401M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.3698M |
| December 31, 2020 | 11.11M |
| September 30, 2020 | 0.4057M |
| June 30, 2020 | 2.310M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | -0.035M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | -0.1945M |
| December 31, 2018 | -0.03M |
| September 30, 2018 | -0.0551M |
| June 30, 2018 | 0.897M |
| March 31, 2018 | 0.047M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.01M |
| September 30, 2017 | 0.0446M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 0.48M |
| September 30, 2015 | 0.06M |
| June 30, 2015 | 0.06M |
| March 31, 2015 | 0.025M |
| December 31, 2011 | -0.0481M |
| September 30, 2011 | 0.0508M |
| June 30, 2011 | 0.0471M |
| March 31, 2011 | 0.0558M |
| December 31, 2010 | -0.112M |
| September 30, 2010 | 0.1496M |
| June 30, 2010 | 0.1049M |
| March 31, 2010 | 0.107M |
| December 31, 2009 | 0.138M |
| September 30, 2009 | 0.519M |
| June 30, 2009 | 0.058M |
| March 31, 2009 | 0.275M |
| December 31, 2008 | 1.144M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.1699M
Minimum
Jun 2023
11.11M
Maximum
Dec 2020
1.328M
Average
0.1575M
Median
Cash from Financing (Quarterly) Benchmarks
| Abbott Laboratories | -1.176B |
| Perspective Therapeutics Inc | 166.33M |
| Xtant Medical Holdings Inc | 5.179M |
| Asensus Surgical Inc | 0.811M |
| Catheter Precision Inc | -0.11M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.2606M |
| Cash from Investing (Quarterly) | -0.0241M |
| Free Cash Flow | -4.362M |
| Free Cash Flow Per Share (Quarterly) | -0.0816 |
| Free Cash Flow to Equity (Quarterly) | -0.4357M |
| Free Cash Flow to Firm (Quarterly) | -0.1288M |
| Free Cash Flow Yield | -225.2% |